The study will follow patients who receive the new Mitris Resilia valve developed by Edwards Lifesciences, according to an April 17 press release.
The valve has already been approved by the FDA, and Hoag has performed more than a dozen mitral valve replacements in the last eight months.
Hoag’s study investigators include surgeons Anthony Caffarelli, MD, Asad Shah, MD, and Timothy Lee, MD.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
